The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | R | Respiratory system | |
2 | R01 | Nasal preparations | |
3 | R01A | Decongestants and other nasal preparations for topical use | |
4 | R01AX | Other nasal preparations |
Code | Title | |
---|---|---|
R01AX01 | Calcium hexamine thiocyanate | |
R01AX02 | Retinol | |
R01AX03 | Ipratropium bromide | |
R01AX05 | Ritiometan | |
R01AX06 | Mupirocin | |
R01AX07 | Hexamidine | |
R01AX08 | Framycetin | |
R01AX09 | Hyaluronic acid | |
R01AX10 | Various | |
R01AX30 | Combinations |
Active Ingredient | Description | |
---|---|---|
Framycetin |
|
|
Hexamidine |
|
|
Hyaluronate sodium |
|
|
Ipratropium |
Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol). |
|
Mupirocin |
Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally. |
|
Ritiometan |
|
Title | Information Source | Document Type | |
---|---|---|---|
ATROVENT HFA Inhalation aerosol, metered | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ATROVENT Nebuliser solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
BACTROBAN 2% Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
BACTROBAN Nasal ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
IPRAVENT Pressurised inhalation, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
MURIPOCIN 2% w/w Ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |